Reporting the NAFT major bleeding rates in context: reviewers should include site investigator-classified rates.
Hull
Russell D
RD
Mah
Andrew F
AF
D000925:Anticoagulants / Q000009:adverse effects*; D017985:Dalteparin / Q000009:adverse effects*; D004311:Double-Blind Method; D006470:Hemorrhage / Q000139:chemically induced*; D006801:Humans; D009656:North America; D012107:Research Design; D012720:Severity of Illness Index
D000925:Anticoagulants; D017985:Dalteparin